Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microtubules | 3 | 2026 | 133 | 0.790 |
Why?
|
| Zebrafish Proteins | 3 | 2026 | 133 | 0.760 |
Why?
|
| Cadherins | 3 | 2026 | 182 | 0.760 |
Why?
|
| Organogenesis | 1 | 2023 | 75 | 0.730 |
Why?
|
| Yolk Sac | 1 | 2022 | 11 | 0.720 |
Why?
|
| Vascular Remodeling | 1 | 2022 | 46 | 0.710 |
Why?
|
| Zebrafish | 3 | 2026 | 418 | 0.680 |
Why?
|
| Atrial Fibrillation | 2 | 2021 | 738 | 0.670 |
Why?
|
| Embryo Implantation | 1 | 2023 | 218 | 0.660 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 127 | 0.630 |
Why?
|
| Inflammasomes | 1 | 2021 | 154 | 0.600 |
Why?
|
| Heart Rate | 2 | 2021 | 577 | 0.570 |
Why?
|
| Heart Atria | 1 | 2021 | 343 | 0.560 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 1075 | 0.480 |
Why?
|
| Epigenomics | 1 | 2015 | 181 | 0.420 |
Why?
|
| Cytoskeleton | 1 | 2015 | 166 | 0.420 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 420 | 0.420 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2014 | 7 | 0.410 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2014 | 62 | 0.400 |
Why?
|
| Inflammation | 1 | 2021 | 1489 | 0.400 |
Why?
|
| Actins | 1 | 2015 | 321 | 0.380 |
Why?
|
| Cell Movement | 1 | 2016 | 876 | 0.370 |
Why?
|
| Histones | 1 | 2016 | 541 | 0.370 |
Why?
|
| Salivary Glands, Minor | 1 | 2011 | 8 | 0.360 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 359 | 0.350 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2011 | 33 | 0.350 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2011 | 63 | 0.340 |
Why?
|
| DNA Methylation | 1 | 2016 | 1077 | 0.300 |
Why?
|
| Obesity | 1 | 2021 | 2426 | 0.300 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 2026 | 0.280 |
Why?
|
| Lung Neoplasms | 2 | 2016 | 1545 | 0.280 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 1419 | 0.270 |
Why?
|
| Animals | 12 | 2026 | 33912 | 0.240 |
Why?
|
| Actin Cytoskeleton | 1 | 2026 | 48 | 0.240 |
Why?
|
| Mice, Knockout | 3 | 2023 | 3819 | 0.220 |
Why?
|
| Embryo, Nonmammalian | 2 | 2026 | 141 | 0.190 |
Why?
|
| X-Ray Microtomography | 1 | 2023 | 101 | 0.180 |
Why?
|
| Cardiomyopathies | 2 | 2022 | 514 | 0.180 |
Why?
|
| Mice | 6 | 2023 | 18301 | 0.180 |
Why?
|
| Calcium Signaling | 2 | 2021 | 243 | 0.180 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2022 | 99 | 0.180 |
Why?
|
| Kv1.5 Potassium Channel | 1 | 2021 | 8 | 0.170 |
Why?
|
| Sheep, Domestic | 1 | 2021 | 17 | 0.170 |
Why?
|
| Action Potentials | 2 | 2021 | 476 | 0.170 |
Why?
|
| Arteries | 1 | 2022 | 208 | 0.160 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2023 | 371 | 0.160 |
Why?
|
| Embryo, Mammalian | 1 | 2022 | 403 | 0.160 |
Why?
|
| Tachycardia, Ventricular | 1 | 2022 | 257 | 0.150 |
Why?
|
| Endothelial Cells | 1 | 2022 | 523 | 0.140 |
Why?
|
| Aurora Kinase B | 1 | 2018 | 12 | 0.140 |
Why?
|
| In Situ Hybridization | 2 | 2017 | 437 | 0.140 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2022 | 482 | 0.140 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 2 | 2010 | 242 | 0.130 |
Why?
|
| Heart Arrest | 1 | 2022 | 356 | 0.130 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 137 | 0.130 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2018 | 70 | 0.130 |
Why?
|
| Down-Regulation | 2 | 2016 | 645 | 0.130 |
Why?
|
| Human papillomavirus 16 | 1 | 2017 | 97 | 0.130 |
Why?
|
| Receptors for Activated C Kinase | 1 | 2016 | 6 | 0.120 |
Why?
|
| Case-Control Studies | 2 | 2021 | 3359 | 0.120 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2016 | 37 | 0.120 |
Why?
|
| Embryonic Development | 1 | 2018 | 200 | 0.120 |
Why?
|
| Histone Demethylases | 1 | 2016 | 41 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 135 | 0.120 |
Why?
|
| Acetylation | 1 | 2016 | 190 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2016 | 240 | 0.110 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 1591 | 0.110 |
Why?
|
| Exocytosis | 1 | 2015 | 65 | 0.110 |
Why?
|
| Mice, Nude | 1 | 2016 | 700 | 0.110 |
Why?
|
| Optical Imaging | 1 | 2015 | 76 | 0.110 |
Why?
|
| RNA Interference | 1 | 2016 | 491 | 0.110 |
Why?
|
| Protein Conformation | 1 | 2016 | 732 | 0.110 |
Why?
|
| Transfection | 1 | 2016 | 962 | 0.110 |
Why?
|
| DNA Primers | 1 | 2015 | 599 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 631 | 0.110 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2017 | 260 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 335 | 0.100 |
Why?
|
| COUP Transcription Factor I | 1 | 2013 | 54 | 0.100 |
Why?
|
| Humans | 10 | 2023 | 131163 | 0.100 |
Why?
|
| Binding Sites | 1 | 2016 | 1133 | 0.100 |
Why?
|
| Ear, Inner | 1 | 2013 | 41 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 484 | 0.100 |
Why?
|
| Heart Ventricles | 1 | 2018 | 749 | 0.100 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 4697 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 526 | 0.100 |
Why?
|
| Models, Molecular | 1 | 2016 | 1064 | 0.100 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 2602 | 0.100 |
Why?
|
| Phenotype | 1 | 2023 | 4497 | 0.090 |
Why?
|
| Papillomavirus Infections | 1 | 2017 | 394 | 0.090 |
Why?
|
| Ovary | 1 | 2015 | 345 | 0.090 |
Why?
|
| Enzyme Activation | 1 | 2014 | 576 | 0.090 |
Why?
|
| Calcium | 3 | 2018 | 1010 | 0.090 |
Why?
|
| Protein Binding | 1 | 2016 | 1652 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 716 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 4738 | 0.090 |
Why?
|
| Eye Neoplasms | 1 | 2011 | 37 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 1363 | 0.090 |
Why?
|
| Genital Neoplasms, Female | 1 | 2011 | 43 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 373 | 0.080 |
Why?
|
| Antibodies, Viral | 1 | 2017 | 1176 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1336 | 0.080 |
Why?
|
| DNA Repair | 1 | 2014 | 571 | 0.080 |
Why?
|
| Mouth Neoplasms | 1 | 2011 | 105 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 157 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2015 | 2550 | 0.070 |
Why?
|
| Cardiomegaly | 1 | 2010 | 117 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2016 | 2465 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 3748 | 0.070 |
Why?
|
| Time Factors | 2 | 2016 | 6196 | 0.070 |
Why?
|
| Female | 5 | 2021 | 70963 | 0.070 |
Why?
|
| Male | 4 | 2021 | 64957 | 0.070 |
Why?
|
| Sex Factors | 1 | 2011 | 1356 | 0.070 |
Why?
|
| Aged | 3 | 2021 | 21025 | 0.070 |
Why?
|
| Isoproterenol | 2 | 2022 | 85 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2013 | 889 | 0.060 |
Why?
|
| Prognosis | 2 | 2017 | 4886 | 0.060 |
Why?
|
| Gastrulation | 1 | 2026 | 26 | 0.060 |
Why?
|
| Age Factors | 1 | 2011 | 2825 | 0.060 |
Why?
|
| Mice, Inbred mdx | 2 | 2018 | 46 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2011 | 909 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 2121 | 0.050 |
Why?
|
| Verapamil | 1 | 2022 | 43 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2026 | 950 | 0.040 |
Why?
|
| Magnesium | 1 | 2022 | 114 | 0.040 |
Why?
|
| Hypertension | 1 | 2010 | 1356 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2022 | 227 | 0.040 |
Why?
|
| Heart Failure | 2 | 2010 | 2332 | 0.040 |
Why?
|
| Middle Aged | 3 | 2018 | 28601 | 0.040 |
Why?
|
| Alopecia | 1 | 2018 | 41 | 0.030 |
Why?
|
| Leukopenia | 1 | 2018 | 44 | 0.030 |
Why?
|
| NADPH Oxidase 2 | 1 | 2018 | 38 | 0.030 |
Why?
|
| Spindle Apparatus | 1 | 2018 | 50 | 0.030 |
Why?
|
| Mitosis | 1 | 2018 | 191 | 0.030 |
Why?
|
| Fatigue | 1 | 2018 | 191 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 387 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 204 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 436 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 318 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2010 | 1571 | 0.030 |
Why?
|
| Age Distribution | 1 | 2017 | 422 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 905 | 0.030 |
Why?
|
| Reference Values | 1 | 2017 | 676 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2018 | 400 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 321 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 787 | 0.030 |
Why?
|
| Myocardium | 2 | 2010 | 852 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 521 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1173 | 0.030 |
Why?
|
| Myocytes, Cardiac | 2 | 2010 | 668 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2013 | 154 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2018 | 791 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 111 | 0.020 |
Why?
|
| Logistic Models | 1 | 2017 | 1797 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 2326 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 2085 | 0.020 |
Why?
|
| Sarcolemma | 1 | 2010 | 13 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2010 | 38 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2010 | 46 | 0.020 |
Why?
|
| Death, Sudden | 1 | 2010 | 45 | 0.020 |
Why?
|
| Cell Size | 1 | 2010 | 77 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2010 | 39 | 0.020 |
Why?
|
| Calcineurin | 1 | 2010 | 60 | 0.020 |
Why?
|
| Incidence | 1 | 2017 | 3360 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2010 | 149 | 0.020 |
Why?
|
| Texas | 1 | 2017 | 3686 | 0.020 |
Why?
|
| Fibrosis | 1 | 2010 | 429 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 3711 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 1013 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1205 | 0.020 |
Why?
|
| Adult | 2 | 2018 | 31282 | 0.020 |
Why?
|
| Echocardiography | 1 | 2010 | 1125 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 10103 | 0.010 |
Why?
|
| Disease Progression | 1 | 2010 | 2200 | 0.010 |
Why?
|
| Aging | 1 | 2010 | 1242 | 0.010 |
Why?
|
| Child | 1 | 2022 | 26341 | 0.010 |
Why?
|
| Mutation | 1 | 2010 | 6099 | 0.010 |
Why?
|